Pawel Gajer
Affiliations: | 2000-2004 | Bioinformatics | The Institute for Genomic Research |
Google:
"Pawel Gajer"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Steven Salzberg | research scientist | 2000-2004 | The Institute for Genomic Research |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| France MT, Fu L, Rutt L, et al. (2022) Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome Biology. 23: 66 |
| Tamarelle J, Ma B, Gajer P, et al. (2019) Non-optimal vaginal microbiota after azithromycin treatment for Chlamydia trachomatis infection. The Journal of Infectious Diseases |
| Edwards VL, Smith SB, McComb EJ, et al. (2019) The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection. Mbio. 10 |
| Thurman AR, Schwartz JL, Ravel J, et al. (2019) Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings. Plos One. 14: e0217229 |
| Elovitz MA, Gajer P, Riis V, et al. (2019) Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. Nature Communications. 10: 1305 |
| Tuddenham S, Ghanem K, Gajer P, et al. (2019) P591 The effect of hormonal contraception on the vaginal microbiota over 2 years Sexually Transmitted Infections. 95 |
| Ma B, McComb E, Gajer P, et al. (2018) Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Frontiers in Microbiology. 9: 2755 |
| Joag V, Obila O, Gajer P, et al. (2018) Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Dausset C, Patrier S, Gajer P, et al. (2018) Comparative phase I randomized open-label pilot clinical trial of Gynophilus (Lcr regenerans) immediate release capsules versus slow release muco-adhesive tablets. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 37: 1869-1880 |
| Girard L, Birse K, Holm JB, et al. (2018) Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates. Scientific Reports. 8: 8059 |